High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.
Genetics and lifestyle influence protein levels in the bloodstream, and this discovery greatly influences the possibilities for using more biomarkers to identify disease.
A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to recent research.
For men with early-stage prostate cancer, watching waiting is not always the best course of action, especially for black patients.
Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.
Cisplatin plus pemetrexed improved response rates and survival rates of patients with advanced cervical cancer.
This fact sheet examines the potential pros and cons of surgery as a means to reduce breast cancer risk.
This fact sheet examines the relationship between secondhand smoke and cancer risk.
Ann J. Brady, MSN, RN-BC
Jia Conway, DNP, FNP-BC, AOCNP, NP-C
Michele M. Farrington, BSN, RN, CPHON
Donald R. Fleming, MD
Arati Jairam-Thodla, MSN, CNP
Karen MacDonald, RN, BSN, CPON
Marlene McGuire, RN, MA, ANP-C
Kerstin L. McSteen, BSN, MSN, ACHPN, CNS-BC
Helen H. Miller, LCSW, ACSW
Maribel Pereiras, PharmD, BCPS, BCOP
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|